Drug – bio-affecting and body treating compositions – Extract or material containing or obtained from an alga as...
Reexamination Certificate
2007-09-04
2007-09-04
Flood, Michele (Department: 1655)
Drug, bio-affecting and body treating compositions
Extract or material containing or obtained from an alga as...
C424S451000, C514S866000
Reexamination Certificate
active
10668601
ABSTRACT:
A method for treating a disease selected from diabetes mellitus and atherosclerosis, and a method for reducing triglycerides and/or increasing HDL cholesterol levels in the plasma of a subject. The method comprises administrating. to a subject an effective amount of crudeDunaliellapowder, optionally together with an activator of nuclear receptors.
REFERENCES:
patent: 4915965 (1990-04-01), Tanaka
patent: 5190970 (1993-03-01), Pan et al.
patent: 5304575 (1994-04-01), Beck
patent: 5972881 (1999-10-01), Heyman et al.
patent: 6362221 (2002-03-01), Clark et al.
patent: 6680387 (2004-01-01), Druzgala et al.
patent: 6914073 (2005-07-01), Boulos et al.
patent: 279561 (2001-01-01), None
patent: 189624 (2003-03-01), None
patent: 10248526 (1998-09-01), None
patent: 2003180387 (2003-07-01), None
patent: WO 98/57636 (1998-12-01), None
patent: WO98/57636 (1998-12-01), None
patent: WO9857636 (1998-12-01), None
patent: WO 9857636 (1998-12-01), None
patent: WO 02/12233 (2000-02-01), None
patent: WO 01/03693 (2000-07-01), None
patent: WO 02/12233 (2002-02-01), None
Levy et al., Annals of Nutrition & Metabolism (2000), 44(2): 54-60. Dietary supplementation of a natural isomer mixture of beta-carotene inhibits oxidation of LDL derived from patients with diabetes mellitus.
Takahashi et al., Aichi Ika Daigaku Igakkai Zasshi (2000), 28(4): 249-255. Decrease of the plasma cholesterol level by administration ofDunaliellaextract in exogenous hypercholesterolemic mice.
Levy et al., Journal of Nutritional & Environmental Medicine (1995), 5: 13-22. Effect of dietary supplemention of different beta-carotene isomers of lipoprotein oxidative modification.
Itoh et al, Aichi Ika Daigaku Igakkai Zasshi (2000), 28(4): 263-271. Inhibitory effect ofDunaliellabeta-carotene extracted fromDunaliella bardawilon plasma lipids of rats.
Harats Dror
Shaish Aviv
Flood Michele
Hopkins Susanne M.
Nikken Sohonsha Corporation
Tel Hashomer Medical Research Infrastructure and Services Ltd.
The Nath Law Group
LandOfFree
Therapeutic uses of Dunaliella powder does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic uses of Dunaliella powder, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic uses of Dunaliella powder will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3793968